Cooper Graham K
Director at BEAM; Chief Financial Officer at Receptos, Inc.; CFO and Treasurer at Orexigen Therapeutics, Inc.
- Sold, on record
- $5.7M
- Dollars the filings state
- Form 4 sales
- 8
- Latest Jul 6, 2021
- Form 144 notices
- 0
- Proposed sales
- Companies
- 3
- Filed as an executive or holder
Companies
- BEAMBeam Therapeutics Inc.Director
- Receptos, Inc.Chief Financial Officer
- Orexigen Therapeutics, Inc.CFO and Treasurer
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- Orexigen Therapeutics, Inc.116,259 shares
- Receptos, Inc.50,000 shares
- BEAM14,659 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale Orexigen Therapeutics, Inc.UnusualNov 20, 2007 2007
Sold 4,000 shares at $14.74 ($59k)
Cooper Graham K, CFO and Treasurer
Sold 100% of holdings ($59k position)0 shares leftFirst sale on recordFiling
- 2 Form 4 sale Orexigen Therapeutics, Inc.UnusualDec 20, 2007 +30 days
Sold 4,000 shares at $14.09 ($56k)
Cooper Graham K, CFO and Treasurer
Sold 100% of holdings ($56k position)0 shares leftFiling
- 3 Form 4 sale Orexigen Therapeutics, Inc.UnusualAug 21, 2008 +245 days
Sold 8,259 shares at $12.00 ($99k)
Cooper Graham K, CFO and Treasurer
Sold 100% of holdings ($99k position)0 shares leftFiling
- 4 Form 4 sale Orexigen Therapeutics, Inc.UnusualDec 21, 2009 +487 days
Sold 82,500 shares at $8.22 ($678k)
Cooper Graham K, CFO and Treasurer
Sold 82.5% of holdings ($822k position)17,500 shares leftFiling
- 5 Form 4 sale Orexigen Therapeutics, Inc.UnusualDec 21, 2009 same day
Sold 17,500 shares at $8.39 ($147k)
Cooper Graham K, CFO and Treasurer
Sold 100% of holdings ($147k position)0 shares leftFiling
- 6 Form 4 sale Receptos, Inc.UnusualSep 16, 2014 +1730 days
Sold 50,000 shares at $61.30 ($3.1M)
Cooper Graham K, Chief Financial Officer
Sold 100% of holdings ($3.1M position)0 shares leftFirst sale on recordFiling
- 7 Form 4 sale BEAMUnusualJun 28, 2021 +2477 days
Sold 12,045 shares at $106.34 ($1.3M)
Cooper Graham K, Director
Sold 100% of holdings ($1.3M position)0 shares leftFirst sale on recordFiling
- 8 Form 4 sale BEAMUnusualJul 6, 2021 +8 days
Sold 2,614 shares at $120.61 ($315k)
Cooper Graham K, Director
Sold 100% of holdings ($315k position)0 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (8)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jul 6, 2021 | Jul 8, 2021 | BEAM | Director | Form 4 sale | 2,614 | $315k | 100.0% | Unusual | SEC |
| Jun 28, 2021 | Jun 30, 2021 | BEAM | Director | Form 4 sale | 12,045 | $1.3M | 100.0% | Unusual | SEC |
| Sep 16, 2014 | Sep 17, 2014 | Receptos, Inc. | Chief Financial Officer | Form 4 sale | 50,000 | $3.1M | 100.0% | Unusual | SEC |
| Dec 21, 2009 | Dec 23, 2009 | Orexigen Therapeutics, Inc. | CFO and Treasurer | Form 4 sale | 17,500 | $147k | 100.0% | Unusual | SEC |
| Dec 21, 2009 | Dec 23, 2009 | Orexigen Therapeutics, Inc. | CFO and Treasurer | Form 4 sale | 82,500 | $678k | 82.5% | Unusual | SEC |
| Aug 21, 2008 | Aug 25, 2008 | Orexigen Therapeutics, Inc. | CFO and Treasurer | Form 4 sale | 8,259 | $99k | 100.0% | Unusual | SEC |
| Dec 20, 2007 | Dec 21, 2007 | Orexigen Therapeutics, Inc. | CFO and Treasurer | Form 4 sale | 4,000 | $56k | 100.0% | Unusual | SEC |
| Nov 20, 2007 | Nov 21, 2007 | Orexigen Therapeutics, Inc. | CFO and Treasurer | Form 4 sale | 4,000 | $59k | 100.0% | Unusual | SEC |